2seventy bio, Inc.
TSVT
$4.99
$0.010.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 73.69% | 48.58% | 13.26% | -3.60% | 14.39% |
| Total Depreciation and Amortization | -31.01% | -11.58% | 4.13% | -1.18% | -10.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -200.06% | -183.32% | -150.19% | -7.49% | -8.55% |
| Change in Net Operating Assets | 15.17% | 12.17% | 126.33% | 146.70% | 109.69% |
| Cash from Operations | 49.06% | 7.78% | 20.97% | 21.64% | 26.86% |
| Capital Expenditure | 94.90% | 92.57% | 87.03% | 74.78% | 55.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -33.66% | 472.56% | 264.57% | -21.53% | 67.02% |
| Cash from Investing | 84.13% | 951.34% | 248.10% | 449.61% | 1,068.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.65% | -99.46% | -99.50% | -99.40% | -25.24% |
| Repurchase of Common Stock | 68.00% | 68.00% | -- | 98.25% | 98.25% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.67% | -99.48% | -99.58% | -99.44% | -23.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -186.91% | 11.74% | 108.45% | -79.93% | 107.55% |